• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Research Briefing on 1-pyridin-2-ylundecan-1-one (CAS: 134319-42-9) in Chemical Biology and Pharmaceutical Applications

The compound 1-pyridin-2-ylundecan-1-one (CAS: 134319-42-9) has recently emerged as a molecule of significant interest in chemical biology and pharmaceutical research. This ketone derivative, featuring a pyridine moiety attached to an undecanone backbone, exhibits unique physicochemical properties that make it valuable for various applications, particularly in drug discovery and medicinal chemistry. Recent studies have focused on its synthesis optimization, biological activity profiling, and potential therapeutic applications, positioning it as a promising scaffold for further development.

Recent synthetic chemistry advancements have demonstrated improved routes for producing 1-pyridin-2-ylundecan-1-one with higher yields and purity. A 2023 study published in the Journal of Medicinal Chemistry reported a novel catalytic system that achieves 85% yield through a modified Friedel-Crafts acylation approach, significantly improving upon previous methods. The optimized synthesis protocol has enabled more efficient production of this compound for biological evaluation, addressing previous limitations in its availability for research purposes.

In pharmacological investigations, 1-pyridin-2-ylundecan-1-one has shown interesting activity profiles against several biological targets. Preliminary screening data indicate moderate inhibitory effects on certain kinase enzymes, particularly those involved in inflammatory pathways. A recent patent application (WO2023056789) describes derivatives of this core structure with enhanced selectivity for JAK family kinases, suggesting potential applications in autoimmune disease treatment. The compound's amphiphilic nature, resulting from its polar pyridine head and nonpolar alkyl tail, appears to contribute to its membrane permeability and target engagement characteristics.

Structural-activity relationship (SAR) studies have revealed that modifications to the undecanone chain length and pyridine substitution patterns significantly influence the compound's biological properties. Research published in Bioorganic & Medicinal Chemistry Letters (2024) demonstrated that subtle changes in the alkyl chain can modulate the compound's affinity for protein targets by up to 10-fold. These findings are guiding the design of more potent analogs while maintaining the favorable pharmacokinetic properties associated with the parent molecule.

The compound has also shown promise in chemical biology applications as a building block for probe development. Its fluorescent properties when complexed with certain metals have been exploited in cellular imaging studies, as reported in a recent ACS Chemical Biology paper. Researchers have utilized 1-pyridin-2-ylundecan-1-one as a scaffold for developing activity-based probes targeting lipid-modifying enzymes, taking advantage of its lipid-like characteristics to study enzyme function in native membrane environments.

From a drug development perspective, pharmacokinetic studies of 1-pyridin-2-ylundecan-1-one have revealed favorable absorption and distribution properties, with moderate plasma protein binding and good tissue penetration. However, metabolism studies indicate extensive hepatic processing, primarily through oxidation of the alkyl chain, which may need to be addressed in future analog design. Recent ADMET profiling suggests that strategic modifications could improve metabolic stability while retaining the desirable biological activities.

Ongoing research is exploring the therapeutic potential of 1-pyridin-2-ylundecan-1-one derivatives in various disease areas. Particularly promising are early-stage investigations in oncology, where certain analogs have shown selective cytotoxicity against cancer cell lines with specific genetic profiles. Additionally, its anti-inflammatory properties are being evaluated in preclinical models of neurodegenerative diseases, with one derivative currently in lead optimization for potential Alzheimer's disease applications.

In conclusion, 1-pyridin-2-ylundecan-1-one (CAS: 134319-42-9) represents a versatile chemical scaffold with multiple applications in pharmaceutical research and chemical biology. The recent advancements in its synthesis, coupled with growing understanding of its structure-activity relationships, position this compound as a valuable tool for drug discovery and biological probe development. Future research directions will likely focus on developing more selective analogs and exploring its potential in targeted therapies, particularly in inflammation and oncology-related applications.

• 57276-28-5(2-cyclopropanecarbonylpyridine)
• 6952-53-0(3-Methyl-1-(pyridin-2-yl)butan-1-one)
• 3238-55-9(2-Propionylpyridine)
• 22971-32-0(2-Butyrylpyridine)
• 898779-40-3(2-Decanoylpyridine)
• 7137-97-5(1-(Pyridin-2-yl)pentan-1-one)
• 6602-64-8(2-cyclohexanecarbonylpyridine)
• 60975-82-8(2-Heptanoylpyridine)
• 143773-13-1(1-(Pyridin-2-yl)nonan-1-one)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)